Acetylcholinesterase inhibitors + memantine
1 paper2 findings
- 1 lab in 1 country
- Funders: National Institute on Aging and 1 more
- Humans1
Outcomes
1Cognitive function
upin humans1
1 study
Cognitive function
upin humans1
Acetylcholinesterase inhibitors + memantine improves cognitive function in humans (+0.7 points).
“while it increased by + 0.7 points (+ 0.4 to + 1.0) in AChEI + /ME + (p:0.001)”
Humanssevere dementiamean: 1.7 ± 0.3 yearsn = 124
GeroScience15 Dec 2025
Associations
1Mortality
downin humans1HR 0.61
1 study
Mortality
downin humans1HR 0.61
Acetylcholinesterase inhibitors + memantine lowers the risk of mortality in humans (HR 0.61, 95% CI 0.49-0.77).
“AChEI + /ME + exhibited a 39% reduction in total mortality compared with no treatment (HR:0.61; 95%CI:0.49-0.77; p < 0.001)”
Humanssevere dementiamean: 1.7 ± 0.3 yearsn = 124
GeroScience15 Dec 2025
Latest
1 in 12 monthsGeroScience
Effectiveness of acetylcholinesterase inhibitors and memantine in patients affected by severe dementia
Cohort study of 703 peopleVascular dementia